연구동향 분석

신경인지기능 장애로서 제2형 당뇨병: 병태생리와 치료적 접근

김지현 ( Jihyun Kim ) 2014년

논문상세정보
인용/피인용
' 신경인지기능 장애로서 제2형 당뇨병: 병태생리와 치료적 접근' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • dementia
  • hypoglycemicagents
  • insulin resistance
  • type 2 diabetes mellitus
  • 인슐린 저항성
  • 제2형 당뇨병
  • 치매
  • 혈당강하제
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
2,641 0

0.0%

' 신경인지기능 장애로서 제2형 당뇨병: 병태생리와 치료적 접근' 의 참고문헌

  • 특집/우리나라 당뇨병의 현황
    김신곤 대한의사협회지 51 (9) : 791 ~ 798 [2008]
  • ‘Type 3 diabetes’: linking a brain insulin-resistant state with dementia and Alzheimer’s disease
    Shaw K Practical Diabetes [2013]
  • Up-regulation of glutamate receptors is associated with LTP defects in the early stages of diabetes mellitus
    Valastro B Diabetologia 45 : 642 ~ 650 [2002]
  • Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI
    den Heijer T Diabetologia 46 : 1604 ~ 1610 [2003]
  • Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia : a preclinical stroke trial
    Culman J Exp Neurol 238 : 243 ~ 253 [2012]
  • Thiazolidinediones and clinical outcomes in type 2 diabetes
    Retnakaran R Lancet 373 : 2088 ~ 2090 [2009]
  • Thiazolidinediones
    Yki-Jarvinen H N Engl J Med 351 : 1106 ~ 1118 [2004]
  • The role of insulin resistance in the pathogenesis of Alzheimer’s disease : implications for treatment
    Watson GS CNS Drugs 17 : 27 ~ 45 [2003]
  • The role of GLP-1 in the life and death of pancreatic beta cells
    Perfetti R Horm Metab Res 36 : 804 ~ 810 [2004]
  • The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
    Kahn SE Diabetologia 46 : 3 ~ 19 [2003]
  • The relationship between type 2 diabetes and dementia
    Strachan MW Br Med Bull 88 : 131 ~ 146 [2008]
  • The prevalence of comorbid depression in adults with diabetes : a meta-analysis
    Anderson RJ Diabetes Care 24 : 1069 ~ 1078 [2001]
  • The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis
    Ali S Diabetic Medicine 23 : 1165 ~ 1173 [2006]
  • The medial temporal lobe
    Squire LR Annu Rev Neurosci 27 : 279 ~ 306 [2004]
  • The mechanisms of action of PPARs
    Berger J Annu Rev Med 53 : 409 ~ 435 [2002]
  • The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
    Drucker DJ Lancet 368 : 1696 ~ 1705 [2006]
  • The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test
    Isacson R Eur J Pharmacol 650 : 249 ~ 255 [2011]
  • The effects of type 1 diabetes on cognitive performance a meta-analysis
    Brands AM Diabetes Care 28 : 726 ~ 735 [2005]
  • The brain in diabetes : molecular changes in neurons and their implications for endorgan damage
    Klein JP Lancet neurology 2 : 548 ~ 554 [2003]
  • The adaptive brain : aging and neurocognitive scaffolding
    Park DC Annu Rev Psychol 60 : 173 ~ 196 [2009]
  • Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products(AGEs)may be a promising biomarker for early detection of Alzheimer’s disease
    Yamagishi S Med Hypotheses 64 : 1205 ~ 1207 [2005]
  • Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study(PROspective pioglitAzone Clinical Trial In macroVascular Events) : a randomised controlled trial
    Dormandy JA Lancet 366 : 1279 ~ 1289 [2005]
  • Rosiglitazone and pioglitazone for the treatment of Alzheimer’s disease
    Miller BW Ann Pharmacother 45 : 1416 ~ 1424 [2011]
  • Role of insulin and insulin receptor in learning and memory
    Zhao WQ Mol Cell Endocrinol 177 : 125 ~ 134 [2001]
  • Risk of dementia in diabetes mellitus: a systematic review
    Biessels GJ Lancet Neurol 5 : 64 ~ 74 [2006]
  • Reward, dopamine and the control of food intake: implications for obesity
    Volkow ND Trends Cogn Sci 15 : 37 ~ 46 [2011]
  • Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors : the action to control cardiovascular risk in diabetes-memory in diabetes(ACCORDMIND)trial
    Cukierman-Yaffe T Diabetes Care 32 : 221 ~ 226 [2009]
  • Quantifying the duration of prediabetes
    Bertram MY Aust N Z J Public Health 34 : 311 ~ 314 [2010]
  • Progression of brain atrophy and cognitive decline in diabetes mellitus : a 3-year follow-up
    van Elderen SGC Neurology 75 : 997 ~ 1002 [2010]
  • Progression of Cerebral Atrophy and White Matter Hyperintensities in Patients With Type 2 Diabetes
    de Bresser J Diabetes Care 33 : 1309 ~ 1314 [2010]
  • Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone : a preliminary study
    Watson GS Am J Geriatr Psychiatry 13 : 950 ~ 958 [2005]
  • Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus
    Yau PL Diabetologia 53 : 2298 ~ 2306 [2010]
  • Potential hippocampal region atrophy in diabetes mellitus type 2 : a voxel-based morphometry VSRAD study
    Kamiyama K Japanese Journal of Radiology 28 : 266 ~ 272 [2010]
  • Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials
    Lincoff AM JAMA 298 : 1180 ~ 1188 [2007]
  • Physiology of incretins in health and disease
    Deacon CF Rev Diabet Stud 8 : 293 ~ 306 [2011]
  • Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide
    Camacho IE J Neurosci 24 : 10908 ~ 10917 [2004]
  • Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents
    Kaundal RK Drug News Perspect 23 : 241 ~ 256 [2010]
  • Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer’s-like changes
    Gupta A Neuropharmacology 60 : 910 ~ 920 [2011]
  • Overweight and obesity are associated with neuronal injury in the human cerebellum and hippocampus in young adults: a combined MRI, serum marker and gene expression study
    Mueller K Transl Psychiatry 2 : e200 ~ [2012]
  • Obesity/hyperleptinemic phenotype impairs structural and functional plasticity in the rat hippocampus
    Grillo CA Physiol Behav 105 : 138 ~ 144 [2011]
  • Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase
    Sastre M J Neurosci 23 : 9796 ~ 9804 [2003]
  • Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons
    El-Mir MY Mol Neurosci 34 : 77 ~ 87 [2008]
  • Neuropathological stageing of Alzheimer-related changes
    Braak H Acta Neuropathol 82 : 239 ~ 259 [1991]
  • Neural plasticity in the ageing brain
    Burke SN Nat Rev Neurosci 7 : 30 ~ 40 [2006]
  • Muscarinic potentiation of GABA(A) receptor currents is gated by insulin signaling in the prefrontal cortex
    Ma XH J Neurosci 23 : 1159 ~ 1168 [2003]
  • Morphometric Changes in Lateral Ventricles of Patients with Recent-Onset Type 2 Diabetes Mellitus
    Lee JH PloS One 8 : e60515 ~ [2013]
  • Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus
    Bruehl H Brain Research 1280 : 186 ~ 194 [2009]
  • Mitochondrial dysfunction is a primary event in glutamate neurotoxicity
    Schinder AF J Neurosci 16 : 6125 ~ 6133 [1996]
  • Mitochondrial dysfunction in the elderly : possible role in insulin resistance
    Petersen KF Science 300 : 1140 ~ 1142 [2003]
  • Mitochondria as a therapeutic target in Alzheimer’s disease and diabetes
    Moreira PI. CNS Neurol Disord Drug Targets 8 : 492 ~ 511 [2009]
  • MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity
    Kusminski CM Nat Med 18 : 1539 ~ 1549 [2012]
  • MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone
    Paddock ML Proc Natl Acad Sci U S A 104 : 14342 ~ 14347 [2007]
  • Metformin, other antidiabetic drugs, and risk of Alzheimer’s disease: a population-based case-control study
    Imfeld P J Am Geriatr Soc 60 : 916 ~ 921 [2012]
  • Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes
    Correia S Med Chem 4 : 358 ~ 364 [2008]
  • Metformin normalizes type 2 diabetes-induced decrease in cell proliferation and neuroblast differentiation in the rat dentate gyrus
    Hwang IK Neurochem Res 35 : 645 ~ 650 [2010]
  • Metformin attenuates Alzheimer’s disease-like neuropathology in obese, leptin-resistant mice
    Li J Pharmacol Biochem Behav 101 : 564 ~ 574 [2012]
  • Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation
    Wang J Cell Stem Cell 11 : 23 ~ 35 [2012]
  • Memory and executive function in aging and AD : multiple factors that cause decline and reserve factors that compensate
    Buckner RL Neuron 44 : 195 ~ 208 [2004]
  • Major depressive disorder
    Belmaker RH N Engl J Med 358 : 55 ~ 68 [2008]
  • Magnetic resonance imaging of the brain in diabetes : the Cardiovascular Determinants of Dementia(CASCADE)Study
    Schmidt R Diabetes 53 : 687 ~ 692 [2004]
  • Linking type 2 diabetes and Alzheimer’s disease
    Han W Proc Natl Acad Sci U S A 107 : 6557 ~ 6558 [2010]
  • Is depression a risk factor for dementia or cognitive decline? A review
    Jorm AF Gerontology 46 : 219 ~ 227 [2000]
  • Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer’s disease and diabetes interrelation
    Correia SC Brain Res 1441 : 64 ~ 78 [2012]
  • Insulin resistance, affective disorders, and Alzheimer’s disease: review and hypothesis
    Rasgon N The journals of gerontology Series A, Biological sciences and medical sciences 59 : 178 ~ 183 [2004]
  • Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study
    Rundek T Arch Neurol 67 : 1195 ~ 1200 [2010]
  • Insulin resistance and risk for stroke
    Kernan WN Neurology 59 : 809 ~ 815 [2002]
  • Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes
    Baker LD Archives of Neurology 68 : 51 ~ 57 [2011]
  • Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis
    Skeberdis VA Proc Natl Acad Sci USA 98 : 3561 ~ 3566 [2001]
  • Insulin and neurodegenerative disease : shared and specific mechanisms
    Craft S Lancet Neurol 3 : 169 ~ 178 [2004]
  • Insulin and ghrelin: peripheral hormones modulating memory and hippocampal function
    McNay EC Curr Opin Pharmacol 7 : 628 ~ 632 [2007]
  • Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle-Aged Adults
    Willette AA Diabetes care 36 : 443 ~ 449 [2013]
  • Inflammatory mechanisms in Alzheimer’s disease : inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists
    Combs CK J Neurosci 20 : 558 ~ 567 [2000]
  • Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer’s disease brains
    Kitamura Y Biochem Biophys Res Commun 254 : 582 ~ 586 [1999]
  • Increased cortical atrophy in patients with Alzheimer’s disease and type 2 diabetes mellitus
    Biessels GJ Journal of Neurology, Neurosurgery, and Psychiatry 77 : 304 ~ 307 [2006]
  • Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin
    Hsu CC J Alzheimers Dis 24 : 485 ~ 493 [2011]
  • Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease--is this type 3 diabetes?
    Steen E J Alzheimers Dis 7 : 63 ~ 80 [2005]
  • Hippocampal synaptic plasticity and glutamate receptor regulation : influences of diabetes mellitus
    Trudeau F Eur J Pharmacol 490 : 177 ~ 186 [2004]
  • Hippocampal damage and memory impairments as possible early brain complications of type 2diabetes
    Gold SM Diabetologia 50 : 711 ~ 719 [2007]
  • Gray matter prefrontal changes in type 2 diabetes detected using MRI
    Kumar A J Magn Reson Imaging 27 : 14 ~ 19 [2008]
  • Glucose metabolism and insulin receptor signal transduction in Alzheimer disease
    Hoyer S Eur J Pharmacol 490 : 115 ~ 125 [2004]
  • Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
    During MJ Nat Med 9 : 1173 ~ 1179 [2003]
  • GLP-1 protects β-cells against apoptosis by enhancing the activity of an IGF-2/IGF1-receptor autocrine loop
    Cornu M Islets 1 : 280 ~ 282 [2009]
  • GLP-1 amplifies insulin signaling by up-regulation of IRbeta, IRS-1 and Glut4 in 3T3-L1 adipocytes
    Gao H Endocrine 32 : 90 ~ 95 [2007]
  • Excitotoxicity and the NMDA receptor--still lethal after eight years
    Rothman SM Trends Neurosci 18 : 57 ~ 58 [1995]
  • Examining a bidirectional association between depressive symptoms and diabetes
    Golden SH JAMA 299 : 2751 ~ 2759 [2008]
  • Evidence of neuronal compensation during episodic memory in subjective memory impairment
    Erk S Arch Gen Psychiatry 68 : 845 ~ 852 [2011]
  • Epidemiology of depression and diabetes: a systematic review
    Roy T J Affect Disord 142 (Suppl) : S8 ~ S21 [2012]
  • Effect of thiazolidinediones and insulin on cognitive outcomes in ACCORDMIND
    Seaquist ER J Diabetes Complications 27 : 485 ~ 491 [2013]
  • Dynamics of gray matter loss in Alzheimer’s disease
    Thompson PM J Neurosci 23 : 994 ~ 1005 [2003]
  • Distinct modulation of voltagegated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons
    Pancani T J Neurochem 109 : 1800 ~ 1811 [2009]
  • Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety
    Deacon CF Expert Opin Pharmacother 14 : 2047 ~ 2058 [2013]
  • Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
    Ding J Diabetes 59 : 2883 ~ 2889 [2010]
  • Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes
    Takeda S Proc Natl Acad Sci U S A 107 : 7036 ~ 7041 [2010]
  • Diabetes mellitus and Alzheimer’s disease: shared pathology and treatment?
    Akter K Br J Clin Pharmacol 71 : 365 ~ 376 [2011]
  • Diabetes in Asia: epidemiology, risk factors, and pathophysiology
    Chan JC JAMA 301 : 2129 ~ 2140 [2009]
  • Diabetes drugs and neurological disorders: new views and therapeutic possibilities
    Patrone C The Lancet Diabetes & Endocrinology [2013]
  • Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis
    Lu FP PLoS One 4 : e4144 ~ [2009]
  • Diabetes and cognitive dysfunction
    McCrimmon RJ Lancet 379 : 2291 ~ 2299 [2012]
  • Diabetes Atlas
    International Diabetes Federation International Diabetes Federation [2003]
  • Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis
    Knol MJ Diabetologia 49 : 837 ~ 845 [2006]
  • Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis
    Ownby RL Arch Gen Psychiatry 63 : 530 ~ 538 [2006]
  • Depression and Type 2 Diabetes Over the Lifespan: A meta-analysis
    Mezuk B Diabetes Care 31 : 2383 ~ 2390 [2008]
  • Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
    Talbot K J Clin Invest 122 : 1316 ~ 1338 [2012]
  • Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer’s disease
    de la Monte SM Drugs 72 : 49 ~ 66 [2012]
  • Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study
    Katon WJ J Gen Intern Med 25 : 423 ~ 429 [2010]
  • Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus
    van Harten B Age and Ageing 36 : 164 ~ 170 [2007]
  • Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus : a comparative study
    Brands AMA Dementia and geriatric cognitive disorders 23 : 343 ~ 350 [2007]
  • Cognitive dysfunction and diabetes mellitus
    Kodl CT Endocr Rev 29 : 494 ~ 511 [2008]
  • Cognition and diabetes: a lifespan perspective
    Biessels GJ Lancet Neurol 7 : 184 ~ 190 [2008]
  • Cerebral cortical thickness in patients with type 2 diabetes
    Brundel M Journal of the Neurological Sciences 299 : 126 ~ 130 [2010]
  • Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes
    Novak V Diabetes Care 29 : 1529 ~ 1534 [2006]
  • Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes
    Manschot SM Diabetes 55 : 1106 ~ 1113 [2006]
  • Brain lesions on MRI in elderly patients with type 2 diabetes mellitus
    van Harten B European Neurology 57 : 70 ~ 74 [2007]
  • Brain insulin resistance accelerates Aβ fibrillogenesis by inducing GM1 ganglioside clustering in the presynaptic membranes
    Yamamoto N Journal of Neurochemistry 121 : 619 ~ 628 [2012]
  • Brain aging in very old men with type 2 diabetes : the Honolulu-Asia Aging Study
    Korf ESC Diabetes Care 29 : 2268 ~ 2274 [2006]
  • Brain Atrophy in Type 2 Diabetes: Regional distribution and influence on cognition
    Moran C Diabetes Care [2013]
  • Biochemistry and molecular cell biology of diabetic complications
    Brownlee M Nature 414 : 813 ~ 820 [2001]
  • Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A(PP2A)signaling
    Kickstein E Proc Natl Acad Sci 107 : 21830 ~ 21835 [2010]
  • Bidirectional association between depression and type 2 diabetes mellitus in women
    Pan A Archives of Internal Medicine 170 : 1884 ~ 1891 [2010]
  • Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats
    Sharma B Pharmacol Biochem Behav 100 : 320 ~ 329 [2011]
  • Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus
    Jongen C Diabetologia 50 : 1509 ~ 1516 [2007]
  • Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64- year-old community sample
    Kumar R The American journal of geriatric psychiatry: Official Journal of the American Association for Geriatric Psychiatry 16 : 989 ~ 998 [2008]
  • Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middleaged adults : the Framingham Offspring Study
    Tan ZS Diabetes Care 34 : 1766 ~ 1770 [2011]
  • Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study
    Katon W Arch Gen Psychiatry 69 : 410 ~ 417 [2012]
  • Association of Depression With Accelerated Cognitive Decline Among Patients With Type 2 Diabetes in the ACCORD-MIND Trial
    Sullivan MD JAMA Psychiatry 70 : 1041 ~ 1047 [2013]
  • Antidiabetic drug metformin(GlucophageR) increases biogenesis of Alzheimer’s amyloid peptides via up-regulating BACE1 transcription
    Chen Y Proc Natl Acad Sci U S A 106 : 3907 ~ 3912 [2009]
  • Analysis of cerebral cortical thickness in patients with type 2 diabetes mellitus -a 6-month longitudinal follow-up study
    Kim JH Seoul national university [2014]
  • Alzheimer’s disease is type 3 diabetes-evidence reviewed
    de la Monte SM J Diabetes Sci Technol : 1101 ~ 1113 [2008]
  • Alzheimer’s disease and type 2 diabetes: Two diseases, one common link?
    Bartl J The world journal of biological psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 14 : 233 ~ 240 [2013]
  • Alzheimer’s disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin
    Moreira PI. J Alzheimers Dis 30 (Suppl 2) : S199 ~ S215 [2012]
  • Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway
    Salkovic-Petrisic M J Neurochem 96 : 1005 ~ 1015 [2006]
  • Alterations in the hippocampal endocannabinoid system in diet-induced obese mice
    Massa F J Neurosci 30 : 6273 ~ 6281 [2010]
  • Aging gracefully : compensatory brain activity in high-performing older adults
    Cabeza R Neuroimage 17 : 1394 ~ 1402 [2002]
  • Advanced glycation end products contribute to amyloidosis in Alzheimer disease
    Vitek MP Proc Natl Acad Sci U S A 91 : 4766 ~ 4770 [1994]
  • Accelerated cognitive decline in patients with type 2 diabetes : MRI correlates and risk factors
    Reijmer YD Diabetes Metab Res Rev 27 : 195 ~ 202 [2011]
  • Accelerated cognitive decline in patients with type 2 diabetes : MRI correlates and risk factors
    Reijmer YD Diabetes/Metabolism Research and Reviews 27 : 195 ~ 202 [2011]
  • A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus
    van den Berg E Diabetologia 53 : 58 ~ 65 [2010]